These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
94 related articles for article (PubMed ID: 25234819)
21. Tenofovir for patients with lamivudine-resistant hepatitis B virus (HBV) infection and high HBV DNA level during adefovir therapy. van Bömmel F; Zöllner B; Sarrazin C; Spengler U; Hüppe D; Möller B; Feucht HH; Wiedenmann B; Berg T Hepatology; 2006 Aug; 44(2):318-25. PubMed ID: 16871563 [TBL] [Abstract][Full Text] [Related]
22. Tenofovir treatment in patients with lamivudine-resistant hepatitis B mutants strongly affects viral replication. van Bömmel F; Wünsche T; Schürmann D; Berg T Hepatology; 2002 Aug; 36(2):507-8. PubMed ID: 12143063 [No Abstract] [Full Text] [Related]
23. [Successful treatment with alpha-interferon of HBV and HDV coinfection. Case report of a 4-year-old boy]. Pawłowska J; Burczyńska B; Kluge P; Socha J Pediatr Pol; 1995 May; 70(5):427-30. PubMed ID: 8692597 [TBL] [Abstract][Full Text] [Related]
24. Tenofovir disoproxil fumarate in the treatment of chronic hepatitis B. Buti M; Homs M Expert Rev Gastroenterol Hepatol; 2012 Aug; 6(4):413-21. PubMed ID: 22928893 [TBL] [Abstract][Full Text] [Related]
26. [Failure to treat hepatitis B virus infection with adefovir due to early selection of rtA181T mutation]. Rodríguez Dominguez M; de la Loma GA; Moreira Vicente V; Mateos Lindemann M Med Clin (Barc); 2010 Apr; 134(10):468-9. PubMed ID: 19464708 [No Abstract] [Full Text] [Related]
27. Treatment of fulminant hepatitis B and fulminant hepatitis B and D coinfection with foscarnet. Hedin G; Weiland O; Ljunggren K; Strömberg A; Nordenfelt E; Hansson BG; Oberg B Prog Clin Biol Res; 1987; 234():309-20. PubMed ID: 2957702 [No Abstract] [Full Text] [Related]
28. Tenofovir disoproxil fumarate exhibits strong antiviral effect in a patient with lamivudine-resistant severe hepatitis B reactivation. Van Bömmel F; Schernick A; Hopf U; Berg T Gastroenterology; 2003 Feb; 124(2):586-7. PubMed ID: 12557178 [No Abstract] [Full Text] [Related]
29. Liver transplantation in bearers of hepatitis B associated or not with delta hepatitis in the age of the new antiviral drugs: is hyperimmune globulin still necessary? Genzini T; Dos Santos RG; Pedrosa C; Curvelo LA; Noujaim HM; Crescentini F; Mota LT; Guirro TG; Ferreira FY; Salomão P; Pereira JR; de Miranda MP Transplant Proc; 2010 Mar; 42(2):496-7. PubMed ID: 20304175 [TBL] [Abstract][Full Text] [Related]
30. Tenofovir rescue regimen following prior suboptimal response to entecavir and adefovir combination therapy in chronic hepatitis B patients exposed to multiple treatment failures. Zhang Q; Han T; Nie CY; Ha FS; Liu L; Liu H J Med Virol; 2015 Jun; 87(6):1013-21. PubMed ID: 25716029 [TBL] [Abstract][Full Text] [Related]
31. Tenofovir-emtricitabine therapy for the prevention of hepatitis B recurrence in four patients after liver transplantation. McGonigal KH; Bajjoka IE; Abouljoud MS Pharmacotherapy; 2013 Sep; 33(9):e170-6. PubMed ID: 23744810 [TBL] [Abstract][Full Text] [Related]
32. Second tenofovir phase III study for the chronic HBV reaches primary endpoint. AIDS Patient Care STDS; 2007 Aug; 21(8):607-8. PubMed ID: 17907310 [No Abstract] [Full Text] [Related]
33. Combination of tenofovir and lamivudine versus tenofovir after lamivudine failure for therapy of hepatitis B in HIV-coinfection. Schmutz G; Nelson M; Lutz T; Sheldon J; Bruno R; von Boemmel F; Hoffmann C; Rockstroh J; Stoehr A; Wolf E; Soriano V; Berger F; Berg T; Carlebach A; Schwarze-Zander C; Schürmann D; Jaeger H; Mauss S AIDS; 2006 Oct; 20(15):1951-4. PubMed ID: 16988516 [TBL] [Abstract][Full Text] [Related]
34. Reactivation of viral replication after replacement of tenofovir by adefovir. van Bömmel F; Berg T Hepatology; 2005 Jul; 42(1):239-40. PubMed ID: 15962310 [No Abstract] [Full Text] [Related]
35. Long-term therapy with adefovir dipivoxil for HBeAg-negative chronic hepatitis B. Mohamadnejad M Arch Iran Med; 2006 Jan; 9(1):90-2. PubMed ID: 16649389 [No Abstract] [Full Text] [Related]
37. Successful treatment of fibrosing cholestatic hepatitis using adefovir dipivoxil in a patient with cirrhosis and renal insufficiency. Tillmann HL; Bock CT; Bleck JS; Rosenau J; Böker KH; Barg-Hock H; Becker T; Trautwein C; Klempnauer J; Flemming P; Manns MP Liver Transpl; 2003 Feb; 9(2):191-6. PubMed ID: 12548514 [TBL] [Abstract][Full Text] [Related]
38. Tenofovir monotherapy is effective in hepatitis B patients with antiviral treatment failure to adefovir in the absence of adefovir-resistant mutations. Tan J; Degertekin B; Wong SN; Husain M; Oberhelman K; Lok AS J Hepatol; 2008 Mar; 48(3):391-8. PubMed ID: 18199519 [TBL] [Abstract][Full Text] [Related]
39. Viral evolutionary changes during tenofovir treatment in a chronic hepatitis B patient with sequential nucleos(t)ide therapy. Lee HW; Chang HY; Yang SY; Kim HJ J Clin Virol; 2014 Jul; 60(3):313-6. PubMed ID: 24836314 [TBL] [Abstract][Full Text] [Related]
40. A novel hepatitis B virus mutation with resistance to adefovir but not to tenofovir in an HIV-hepatitis B virus-co-infected patient. Lacombe K; Ollivet A; Gozlan J; Durantel S; Tran N; Girard PM; Zoulim F AIDS; 2006 Nov; 20(17):2229-31. PubMed ID: 17086064 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]